| 8718946 |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Michael P. Bevilacqua, Victor Tryon, Danute Bankaitis-Davis |
2014-05-06 |
|
| 8055452 |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Michael P. Bevilacqua, Victor Tryon, Danute Bankaitis-Davis |
2011-11-08 |
$34,583,000 |
| 7957909 |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Michael P. Bevilacqua, Victor Tryon, Danute Bankaitis-Davis |
2011-06-07 |
|
| 7074586 |
Quantitative assay for low abundance molecules |
David B. Trollinger |
2006-07-11 |
|
| 6964850 |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Michael P. Bevilacqua, Victor Tryon, Danute Bankaitis-Davis |
2005-11-15 |
|
| 6960439 |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Michael P. Bevilacqua, Danute Bankaitis-Davis, Victor Tryon |
2005-11-01 |
|
| 6777403 |
Method and structure for inhibiting activity of serine elastases |
— |
2004-08-17 |
$112,000 |
| 6692916 |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles |
Michael P. Bevilacqua, Danute Bankaitis-Davis, Victor Tryon |
2004-02-17 |
|
| 6569876 |
Method and structure for inhibiting activity of serine elastases |
— |
2003-05-27 |
|
| 6375951 |
Therapeutic suppression of specific immune response by administration of oligomeric forms of antigen of controlled chemistry |
Howard M. Dintzis, Renee Z. Dintzis, James K. Blodgett, Gary P. Kirschenheuter |
2002-04-23 |
|
| 6159938 |
Serine protease inhibitors comprising .alpha.-keto heterocycles |
Albert Gyorkos, Lyle W. Spruce, Axel Leimer |
2000-12-12 |
$365,000 |
| 6075120 |
Bradykinin antagonist |
James K. Blodgett, Val S. Goodfellow, Manoj Vinayak Marathe, Lyle W. Spruce, Eric T. Whalley |
2000-06-13 |
$272,000 |
| 6022544 |
Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
Howard M. Dintzis, Renee Z. Dintzis, James K. Blodgett, Gary P. Kirschenheuter |
2000-02-08 |
|
| 6004933 |
Cysteine protease inhibitors |
Lyle W. Spruce, Albert Gyorkos, Val S. Goodfellow, Axel Leimer, John M. Young +1 more |
1999-12-21 |
$120,000 |
| 5863899 |
Bradykinin antagonists |
James K. Blodgett, Val S. Goodfellow, Manoj Vinayak Marathe, Lyle W. Spruce, Eric T. Whalley |
1999-01-26 |
$310,000 |
| 5843900 |
Bradykinin antagonists |
Albert Gyorkos, Lyle W. Spruce, Eric T. Whalley |
1998-12-01 |
|
| 5663416 |
Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
Gary P. Kirschenheuter, Lyle W. Spruce |
1997-09-02 |
$336,000 |
| 5635593 |
Bradykinin antagonists |
James K. Blodgett, Eric T. Whalley, Shadrach R. Eubanks, Lisa G. Allen, Khe T. Nguyen |
1997-06-03 |
$332,000 |
| 5620958 |
Bradykinin antagonists |
James K. Blodgett, Eric T. Whalley, Shadrach R. Eubanks, Lisa G. Allen, Khe T. Nguyen |
1997-04-15 |
|
| 5573916 |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier |
Claire Coeshott |
1996-11-12 |
|
| 5416191 |
Bradykinin antagonists |
Eric T. Whalley, Khe T. Nguyen, Shadrach R. Eubanks, Lisa G. Allen |
1995-05-16 |
$1,222,000 |
| 5314910 |
Ester inhibitors |
Gary P. Kirschenheuter, Raymond T. Cunningham |
1994-05-24 |
$3,428,000 |
| 5281617 |
N-succinimidyl and N-phthalimidyl esters of 2-phenylalkanoic acid derivatives as inhibitors of human leukocyte elastase |
Gary P. Kirschenheuter |
1994-01-25 |
$4,646,000 |
| 5240956 |
Ester inhibitors |
Gary P. Kirschenheuter, Raymond T. Cunningham |
1993-08-31 |
$4,309,000 |
| 5214191 |
Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase |
Gary P. Kirschenheuter, Lyle W. Spruce |
1993-05-25 |
$2,688,000 |
